Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications
about
Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human diseaseBardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.Comparative Proteomic Characterization of 4 Human Liver-Derived Single Cell Culture Models Reveals Significant Variation in the Capacity for Drug Disposition, Bioactivation, and Detoxication.Adaptation to acetaminophen exposure elicits major changes in expression and distribution of the hepatic proteome.Integrated transcriptomic and proteomic analyses uncover regulatory roles of Nrf2 in the kidney.Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus.Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.CDDO and Its Role in Chronic Diseases.Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes.Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease.Oxidative stress serves as a key checkpoint for IL-33 release by airway epithelium.Real-time in vivo imaging reveals localised Nrf2 stress responses associated with direct and metabolism-dependent drug toxicity.Nrf2, the Master Regulator of Anti-Oxidative Responses.Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
P2860
Q28608628-4931ADE3-F7A5-4ED1-8157-CE08C42FC878Q34415403-11843320-ED07-4F29-B9FF-8C87AD6E646DQ36093125-6E93092F-C1E8-4928-8B6B-19BEF8F76BD1Q36320801-19E4B89A-419B-4F69-8241-C6B34830A86DQ36364169-D4829FC0-AEE3-4362-9893-B3C6D3422857Q36763283-C036BCED-6103-437F-BA4E-5F112261965EQ37370522-F9CE3621-D999-437E-8154-BD2A4A7E3DC3Q38807055-570FD4FC-48DA-43AA-9727-93E2132496D9Q40060254-2A648647-CBC6-44EA-8E5C-D570E0800573Q40770241-C68F0DB2-DCF7-454A-ABBD-3B4CBCF4CF42Q46407290-6377F64E-2E1E-4998-AF0E-254F47B2185EQ47147696-EA682175-3055-4A54-B763-7412133985B1Q47250925-83C4D109-5AC7-4CA7-B49F-675A533C4DDFQ52883193-71E5CD56-FCBA-469D-A974-D0BCE7F8A6BD
P2860
Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Identification and quantificat ...... and toxicological implications
@ast
Identification and quantificat ...... and toxicological implications
@en
type
label
Identification and quantificat ...... and toxicological implications
@ast
Identification and quantificat ...... and toxicological implications
@en
prefLabel
Identification and quantificat ...... and toxicological implications
@ast
Identification and quantificat ...... and toxicological implications
@en
P2093
P2860
P50
P1476
Identification and quantificat ...... and toxicological implications
@en
P2093
Adedamola Olayanju
B Kevin Park
Christopher E P Goldring
Helen Powell
Neil R Kitteringham
Paul M O'Neill
P2860
P304
P356
10.1016/J.JPROT.2014.05.007
P577
2014-05-21T00:00:00Z